Wall Street Access Asset Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Wall Street Access Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 15, 2019	SELL	$5.26 - $7.97 $60,490 - $91,655	-11,500 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$5.05 - $6.8 $58,075 - $78,200	11,500 New	11,500 $58,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $755M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.